NCT06097845 Transcranial Ultrasound Via Sonolucent Cranioplasty
| NCT ID | NCT06097845 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwell Health |
| Condition | Cranioplasty |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-06-27 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-06-27 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Transcranial Ultrasound via Sonolucent Cranioplasty is a prospective, single arm, observational, open label (non-blinded) study to collect real world evidence on the use of transcranial ultrasound via sonolucent cranioplasty.
Eligibility Criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. Patients who are undergoing reconstructive sonolucent cranioplasty as standard of care. 4. Male or female, aged ≥ 18. Exclusion Criteria: 1\. Patients who are pregnant
Contact & Investigator
Netanel Ben-Shalom, MD
PRINCIPAL INVESTIGATOR
Lenox Hill Hospital
Frequently Asked Questions
Who can join the NCT06097845 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cranioplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06097845 currently recruiting?
Yes, NCT06097845 is actively recruiting participants. Contact the research team at nbenshalom@northwell.edu for enrollment information.
Where is the NCT06097845 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06097845 clinical trial?
NCT06097845 is sponsored by Northwell Health. The principal investigator is Netanel Ben-Shalom, MD at Lenox Hill Hospital. The trial plans to enroll 50 participants.